UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period Ended February 29, 2008

 

or

 

o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _____ to _____

 

Commission File Number 000-19364

 


 

HEALTHWAYS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

 

62-1117144

(State or Other Jurisdiction of

 

(I.R.S. Employer

Incorporation or Organization)

 

Identification No.)

 

3841 Green Hills Village Drive, Nashville, TN 37215

(Address of Principal Executive Offices) (Zip Code)

 

615-665-1122

(Registrant’s Telephone Number, Including Area Code)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes x No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

 


Large accelerated filer x Accelerated filer o Non-accelerated filer o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes o No x

 

As of April 3, 2008 there were outstanding 35,140,869 shares of the Registrant’s Common Stock, par value $.001 per share.

 

2

 


Healthways, Inc.

Form 10-Q

Table of Contents

 

 

 

 

 

Page

Part I

 

 

 

 

Item 1.

Financial Statements

4

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and

Results of Operations

 

15

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

29

 

Item 4.

Controls and Procedures

30

Part II

 

 

 

 

Item 1.

Legal Proceedings

30

 

Item 1A.

Risk Factors

31

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

31

 

Item 3.

Defaults Upon Senior Securities

31

 

Item 4.

Submission of Matters to a Vote of Security Holders

31

 

Item 5.

Other Information

32

 

Item 6.

Exhibits

32

 

 

3

 


Part I

 

Item 1.

Financial Statements

 

HEALTHWAYS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 

ASSETS

 

 

 

 

February 29,

 

 

 

August 31,

 

 

 

2008

 

 

 

2007

 

Current assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

40,686

 

 

 

$

47,655

 

Accounts receivable, net

 

 

106,685

 

 

 

 

80,201

 

Prepaid expenses

 

 

8,724

 

 

 

 

10,370

 

Other current assets

 

 

6,230

 

 

 

 

4,319

 

Income taxes receivable

 

 

1,652

 

 

 

 

1,741

 

Deferred tax asset

 

 

7,185

 

 

 

 

7,145

 

Total current assets

 

 

171,162

 

 

 

 

151,431

 

 

 

 

 

 

 

 

 

 

 

Property and equipment:

 

 

 

 

 

 

 

 

 

Leasehold improvements

 

 

22,717

 

 

 

 

19,268

 

Computer equipment and related software

 

 

108,307

 

 

 

 

87,843

 

Furniture and office equipment

 

 

22,035

 

 

 

 

20,435

 

Capital projects in process

 

 

34,361

 

 

 

 

12,336

 

 

 

 

187,420

 

 

 

 

139,882

 

Less accumulated depreciation

 

 

(94,224

)

 

 

 

(81,160

)

 

 

 

93,196

 

 

 

 

58,722

 

 

 

 

 

 

 

 

 

 

 

Long-term deferred tax asset

 

 

1,855

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets

 

 

16,615

 

 

 

 

15,609

 

 

 

 

 

 

 

 

 

 

 

Customer contracts, net

 

 

38,144

 

 

 

 

41,777

 

Other intangible assets, net

 

 

74,213

 

 

 

 

77,722

 

Goodwill, net

 

 

484,114

 

 

 

 

483,584

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

879,299

 

 

 

$

828,845

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to the consolidated financial statements.

 

 

 

 

 

 

 

 

4

 


HEALTHWAYS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

February 29,

 

 

 

August 31,

 

 

 

2008

 

 

 

2007

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

$

15,537

 

 

$

13,630

 

Accrued salaries and benefits

 

29,946

 

 

 

18,960

 

Accrued liabilities

 

23,161

 

 

 

22,146

 

Deferred revenue

 

8,490

 

 

 

7,918

 

Contract billings in excess of earned revenue

 

76,243

 

 

 

72,829

 

Current portion of long-term debt

 

2,153

 

 

 

2,213

 

Current portion of long-term liabilities

 

2,962

 

 

 

2,943

 

Total current liabilities

 

158,492

 

 

 

140,639

 

 

 

 

 

 

 

 

 

Long-term debt

 

276,016

 

 

 

297,059

 

Long-term deferred tax liability

 

 

 

 

14,009

 

Other long-term liabilities

 

43,413

 

 

 

14,388

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

Preferred stock

 

 

 

 

 

 

 

$.001 par value, 5,000,000 shares

 

 

 

 

 

 

 

authorized, none outstanding

 

 

 

 

 

Common stock

 

 

 

 

 

 

 

$.001 par value, 120,000,000 and 75,000,000 shares authorized,

 

 

 

 

 

 

 

36,049,937 and 35,606,482 shares outstanding

 

36

 

 

 

35

 

Additional paid-in capital

 

210,895

 

 

 

188,126

 

Retained earnings

 

193,435

 

 

 

174,641

 

Accumulated other comprehensive loss

 

(2,988

)

 

 

(52

)

Total stockholders’ equity

 

401,378

 

 

 

362,750

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

$

879,299

 

 

$

828,845

 

 

 

 

 

 

 

 

 

See accompanying notes to the consolidated financial statements.

 

 

 

 

 

 

 

5

 


HEALTHWAYS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except earnings per share data)

(Unaudited)

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

February 29/28,

 

February 29/28,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

178,966

 

$

160,281

 

$

354,786

 

$

277,336

 

Cost of services (exclusive of depreciation and amortization of $7,475, $7,458, $15,285, and $13,093, respectively, included below)

 

 

125,357

 

 

109,020

 

 

249,543

 

 

186,569

 

Selling, general & administrative expenses

 

 

16,846

 

 

16,476

 

 

33,694

 

 

29,059

 

Depreciation and amortization

 

 

10,605

 

 

10,268

 

 

21,063

 

 

17,085

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

 

26,158

 

 

24,517

 

 

50,486

 

 

44,623

 

Interest expense

 

 

4,993

 

 

6,251

 

 

10,335

 

 

6,547

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

 

21,165

 

 

18,266

 

 

40,151

 

 

38,076

 

Income tax expense

 

 

8,711

 

 

7,242

 

 

16,514

 

 

15,218

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

12,454

 

$

11,024

 

$

23,637

 

$

22,858

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.35

 

$

0.32

 

$

0.66

 

$

0.66

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

$

0.33

 

$

0.30

 

$

0.63

 

$

0.62

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares and equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

36,031

 

 

34,958

 

 

35,873

 

 

34,792

 

Diluted

 

 

37,911

 

 

36,935

 

 

37,801

 

 

36,763

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to the consolidated financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

6

 


HEALTHWAYS, INC.

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

For the Six Months Ended February 29, 2008

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

Other

 

 

 

 

 

 

 

Preferred

 

Common

 

Paid-in

 

Retained

 

Comprehensive

 

 

 

 

 

 

 

Stock

 

Stock

 

Capital

 

Earnings

 

Loss

 

Total

 

 

 

Balance, August 31, 2007

 

 

$—

 

 

$35

 

 

$188,126

 

 

$174,641

 

 

 

$(52

)

 

$362,750

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative effect of change in accounting

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

principle – adoption of FIN 48

 

 

 

 

 

 

 

 

(687

)

 

 

 

 

(687

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

23,637

 

 

 

 

 

23,637

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net change in fair value of interest rate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

swaps, net of income taxes of $2,298

 

 

 

 

 

 

 

 

 

 

 

(3,295

)

 

(3,295

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

359 

 

 

359

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,701

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of stock options

 

 

 

 

1

 

 

5,787

 

 

 

 

 

— 

 

 

5,788

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchases of common stock

 

 

 

 

 

 

(464

)

 

(4,156

)

 

 

 

 

(4,620

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax benefit of option exercises

 

 

 

 

 

 

9,456

 

 

— 

 

 

 

— 

 

 

9,456

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share-based employee compensation expense

 

 

 

 

 

 

7,990

 

 

— 

 

 

 

— 

 

 

7,990

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, February 29, 2008

 

 

$—

 

 

$36

 

 

$210,895

 

 

$193,435

 

 

 

$(2,988

)

 

$401,378

 

 

 

See accompanying notes to the consolidated financial statements.

 

7

 


HEALTHWAYS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

 

Six Months Ended

February 29/28,

 

 

 

2008

 

 

 

2007

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net income

 

$

23,637

 

 

 

$

22,858

 

Adjustments to reconcile net income to net cash provided by

 

 

 

 

 

 

 

 

 

operating activities, net of business acquisitions:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

21,063

 

 

 

 

17,085

 

Amortization of deferred loan costs

 

 

583

 

 

 

 

405

 

Share-based employee compensation expense

 

 

7,990

 

 

 

 

8,204

 

Excess tax benefits from share-based payment arrangements

 

 

(9,127

)

 

 

 

(4,117

)

Increase in accounts receivable, net

 

 

(26,504

)

 

 

 

(15,653

)

Increase in other current assets

 

 

(279

)

 

 

 

(85

)

Increase (decrease) in accounts payable

 

 

360

 

 

 

 

(1,156

)

Increase (decrease) in accrued salaries and benefits

 

 

10,986

 

 

 

 

(17,414

)

Increase in other current liabilities

 

 

16,119

 

 

 

 

17,617

 

Deferred income taxes

 

 

(3,055

)

 

 

 

(5,708

)

Other

 

 

11,681

 

 

 

 

1,990

 

(Increase) decrease in other assets

 

 

(1,589

)

 

 

 

1,768

 

Payments on other long-term liabilities

 

 

(1,900

)

 

 

 

(1,154

)

Net cash flows provided by operating activities

 

 

49,965

 

 

 

 

24,640

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Acquisition of property and equipment

 

 

(45,832

)

 

 

 

(7,620

)

Acquisitions, net of cash acquired

 

 

(294

)

 

 

 

(456,725

)

Other, net

 

 

 

 

 

 

(13

)

Net cash flows used in investing activities

 

 

(46,126

)

 

 

 

(464,358

)

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Proceeds from issuance of long-term debt

 

 

 

 

 

 

350,000

 

Deferred loan costs

 

 

 

 

 

 

(4,357

)

Proceeds from sale of unregistered common stock

 

 

 

 

 

 

5,000

 

Repurchases of common stock

 

 

(4,620

)

 

 

 

 

Excess tax benefits from share-based payment arrangements

 

 

9,127

 

 

 

 

4,117

 

Payments of long-term debt

 

 

(21,103

)

 

 

 

(20,089

)

Exercise of stock options

 

 

5,788

 

 

 

 

2,632

 

Net cash flows (used in) provided by financing activities

 

 

(10,808

)

 

 

 

337,303 

 

 

 

 

 

 

 

 

 

 

 

Net decrease in cash and cash equivalents

 

 

(6,969

)

 

 

 

(102,415

)

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents, beginning of period

 

 

47,655

 

 

 

 

154,792

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents, end of period

 

$

40,686

 

 

 

$

52,377

 

 

 

See accompanying notes to the consolidated financial statements.

 

8

 


HEALTHWAYS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

 

(1)

Interim Financial Reporting

 

The accompanying consolidated financial statements of Healthways, Inc. and its wholly-owned subsidiaries for the three and six months ended February 29, 2008 and February 28, 2007 are unaudited. However, in our opinion, the consolidated financial statements reflect all adjustments consisting of normal, recurring accruals necessary for a fair presentation. We have reclassified certain items in prior periods to conform to current classifications.

 

We have omitted certain financial information that is normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States but that is not required for interim reporting purposes. You should read the accompanying consolidated financial statements in conjunction with the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2007.

 

(2)

Recently Issued Accounting Standards

 

Fair Value Measurement

 

In September 2006 the Financial Accounting Standards Board (“FASB”) issued Statements of Financial Accounting Standards (“SFAS”) No. 157, “Fair Value Measurement,” which provides guidance for using fair value to measure assets and liabilities, including a fair value hierarchy that prioritizes the information used to develop fair value assumptions.  It also requires expanded disclosure about the extent to which companies measure assets and liabilities at fair value, the information used to measure fair value, and the effect of fair value measurements on earnings.  The standard applies whenever other standards require (or permit) assets or liabilities to be measured at fair value and does not expand the use of fair value in any new circumstances.  SFAS No. 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years.

 

In February 2008, the FASB issued FASB Staff Position (“FSP”) FAS No. 157-2, “Effective Date of FASB Statement No. 157”, which defers by one year the effective date of the provisions of SFAS No. 157 for non-recurring, nonfinancial assets and nonfinancial liabilities to fiscal years beginning after November 15, 2008. We do not expect the adoption of SFAS No. 157 to have a material impact on our financial position or results of operations.

Business Combinations

In December 2007, the FASB issued SFAS No. 141(R), “Business Combinations”. This statement expands the definition of a business and a business combination and generally requires the acquiring entity to recognize all of the assets and liabilities of the acquired business, regardless of the percentage ownership acquired, at their fair values. It also requires that contingent consideration and certain acquired contingencies be recorded at fair value on the acquisition date and that acquisition costs generally be expensed as incurred.

 

9

 


SFAS No. 141(R) is effective for fiscal years beginning after December 15, 2008. We have not yet completed our analysis of the impact that the implementation of SFAS No. 141(R) will have on our results of operations or financial condition.

Accounting for Uncertainty in Income Taxes

 

On September 1, 2007, we adopted the provisions of FASB Interpretation (“FIN”) No. 48, “Accounting for Uncertainty in Income Taxes - an interpretation of FASB Statement No. 109” (see Note 4). FIN No. 48 creates a single model to address uncertainty in income tax positions by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. It also provides guidance on derecognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and income tax disclosures.

 

(3)

Share-Based Compensation

 

We have several shareholder-approved stock incentive plans for employees and directors. We currently have three types of share-based awards outstanding under these plans: stock options, restricted stock, and restricted stock units. We believe that such awards align the interests of our employees and directors with those of our stockholders. We account for share-based compensation in accordance with SFAS No. 123(R), “Share-Based Payment.” For the three and six months ended February 29, 2008, we recognized share-based compensation costs of $3.8 million and $8.0 million, respectively. For the three and six months ended February 28, 2007, we recognized share-based compensation costs of $4.2 million and $8.2 million, respectively.

 

In October 2007, we granted annual equity awards, including stock options and restricted stock units, for fiscal 2007 performance. A summary of our stock options as of February 29, 2008 and changes during the six months then ended is presented below:

 

Options

 

 

 

Shares (000s)

 

 

Weighted-Average Exercise Price

 

Weighted-Average Remaining Contractual Term

 

 

Aggregate Intrinsic Value ($000s)

 

 

Outstanding at September 1, 2007

 

 

 

5,245

 

 

$

22.46

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

470

 

 

 

54.60

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

(536

)

 

 

10.92

 

 

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

 

(107

)

 

 

38.71

 

 

 

 

 

 

 

 

 

 

 

Outstanding at February 29, 2008

 

 

 

5,072

 

 

$

26.32

 

 

 

5.27

 

 

 

$

61,693

 

 

Exercisable at February 29, 2008

 

 

 

2,599

 

 

$

13.23

 

 

 

4.65

 

 

 

$

55,245

 

 

 

The weighted-average grant-date fair value of options granted during the three and six months ended February 29, 2008 was $23.95 and $25.27, respectively.

 

The following table shows a summary of our restricted stock and restricted stock units (“nonvested shares”) as of February 29, 2008 as well as activity during the six months then ended.

 

 

 

10

 


 

Nonvested Shares

 

 

 

Shares (000s)

 

 

Weighted-Average Grant Date Fair Value

 

 

Nonvested at September 1, 2007

 

 

 

364

 

 

$

43.76

 

 

 

Granted

 

 

 

147

 

 

 

54.81

 

 

 

Vested

 

 

 

(1

)

 

 

34.84

 

 

 

Forfeited

 

 

 

(21

)

 

 

46.05

 

 

 

Nonvested at February 29, 2008

 

 

 

489

 

 

$

47.00

 

 

 

 

(4)

Income Taxes

 

We adopted the provisions of FIN No. 48 on September 1, 2007. FIN No. 48 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. FIN No. 48 also provides guidance on derecognition, classification, interest and penalties, accounting for interim periods, disclosure and transition.

 

Adopting FIN No. 48 had the following impact on our financial statements: increased long-term liabilities by $11.9 million; decreased our income taxes payable by $0.2 million; decreased long-term deferred tax liabilities by $11.0 million; and decreased our retained earnings by $0.7 million. As of September 1, 2007, we had $11.1 million of unrecognized tax benefits of which $0.4 million, if recognized, would affect our effective tax rate. Our policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. As of September 1, 2007, we had accrued interest related to uncertain tax positions of $0.8 million on our balance sheet.

 

We file income tax returns in the U.S. Federal jurisdiction and in various state and foreign jurisdictions. Tax years remaining subject to examination in these jurisdictions include 2004 to present.

 

(5)

Derivative Investments and Hedging Activities

 

SFAS No. 133, “Accounting for Derivative Investments and Hedging Activities,” as amended, establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. It requires companies to record all derivatives at estimated fair value as either assets or liabilities on the balance sheet and to recognize the unrealized gains and losses, the treatment of which depends on whether the derivative is designated as a hedging instrument.

 

As a result of our international initiatives, we are exposed to foreign currency exchange rate risks. A significant portion of these risks is economically hedged with currency options and forward contracts in order to minimize our exposure to fluctuations in foreign currency exchange rates. Principal currencies hedged include the Euro and British pound. These derivative instruments serve as economic hedges and do not qualify for hedge accounting treatment under SFAS No. 133. Accordingly, they require current period mark-to-market accounting, with any change in fair value being recorded each period in the statement of operations. We record the fair market value of our derivatives, based on information provided by reliable third parties, as other current assets or accrued liabilities. We routinely monitor our foreign currency exposures to maximize the overall effectiveness of our foreign currency hedge positions.

 

We maintain two interest rate swap agreements to reduce our exposure to interest rate fluctuations on our floating rate debt commitments. Under these interest rate swap agreements, the interest rate is fixed with respect to specified amounts of notional principal. The swaps are accounted for in accordance

 

11

 


with SFAS No. 133 and were designated at their inception as qualifying cash flow hedges; thus, they are recorded at estimated fair value in the balance sheet, with changes in fair value being reported in other comprehensive income. The fair value of the swaps at February 29, 2008 of ($5.9) million has been reported in other long-term liabilities with an offset, net of tax, included in “accumulated other comprehensive loss” in the consolidated balance sheet.

 

(6)

Long-Term Debt

 

On December 1, 2006, we entered into a Third Amended and Restated Revolving Credit and Term Loan Agreement (the “Third Amended Credit Agreement”). The Third Amended Credit Agreement provides us with a $400.0 million revolving credit facility, including a swingline sub facility of $10.0 million and a $75.0 million sub facility for letters of credit, a $200.0 million term loan facility, and an uncommitted incremental accordion facility of $200.0 million. As of February 29, 2008, availability under our revolving credit facility totaled $317.9 million.

 

Revolving advances under the Third Amended Credit Agreement generally bear interest, at our option, at 1) LIBOR plus a spread of 0.875% to 1.750% or 2) the greater of the federal funds rate plus 0.5%, or the prime rate, plus a spread of 0.000% to 0.250%. Term loan borrowings bear interest, at our option, at 1) LIBOR plus 1.50% or 2) the greater of the federal funds rate plus 0.5%, or the prime rate. The Third Amended Credit Agreement also provides for a fee ranging between 0.150% and 0.300% of unused commitments. The Third Amended Credit Agreement is secured by guarantees from most of the Company’s domestic subsidiaries and by security interests in substantially all of the Company’s and such subsidiaries’ assets.

 

We are required to repay outstanding revolving loans on the revolving commitment termination date, which is December 1, 2011. We are required to repay term loans in quarterly principal installments aggregating $0.5 million each, which commenced on March 31, 2007, and the entire unpaid principal balance of the term loans is due and payable at maturity on December 1, 2013.

 

The Third Amended Credit Agreement contains various financial covenants, which require us to maintain, as defined, ratios or levels of (i) total funded debt to EBITDA, (ii) fixed charge coverage, and (iii) net worth. It also restricts the payment of dividends and limits the amount of repurchases of the Company’s common stock. On December 21, 2006, we entered into an amortizing interest rate swap agreement for the management of interest rate exposure. By entering into this interest rate swap agreement, we effectively converted $230.0 million of floating rate debt to a fixed obligation with an interest rate of 4.995%. The principal value of the swap arrangement amortizes over a 39-month period and terminates on March 31, 2010. In addition, we entered into a second interest rate swap agreement on December 11, 2007. By entering into this interest rate swap agreement, we effectively converted $40.0 million of floating rate debt to a fixed obligation with an interest rate of 3.987%. We currently believe that we meet the hedge accounting criteria under SFAS No. 133 in accounting for these interest rate swap agreements.

 

(7)

Commitments and Contingencies

 

Pursuant to an earn-out agreement executed in connection with the acquisition of certain assets of Health IQ in June 2005, we are obligated to pay the former stockholders of Health IQ additional purchase price equal to a percentage of revenues recognized from Health IQ’s programs in each of the fiscal quarters during the three-year period ending August 31, 2008.

 

In June 1994, a former employee whom we dismissed in February 1994 filed a “whistle blower” action on behalf of the United States government. Subsequent to its review of this case, the federal

 

12

 


government determined not to intervene in the litigation. The employee sued Healthways, Inc. and our wholly-owned subsidiary, American Healthways Services, Inc. (“AHSI”), as well as certain named and unnamed medical directors and one named client hospital, West Paces Medical Center (“WPMC”), and other unnamed client hospitals.

 

Healthways, Inc. has since been dismissed as a defendant; however, the case is still pending against AHSI before the United States District Court for the District of Columbia. In addition, WPMC has settled claims filed against it as part of a larger settlement agreement that WPMC’s parent organization, HCA Inc., reached with the United States government. The plaintiff has also dismissed its claims against the medical directors with prejudice, and on February 7, 2007 the court granted the plaintiff’s motion and dismissed all claims against all named medical directors.

 

The complaint alleges that AHSI, the client hospitals and the medical directors violated the federal False Claims Act by entering into certain arrangements that allegedly violated the federal anti-kickback statute and provisions of the Social Security Act prohibiting physician self-referrals. Although no specific monetary damage has been claimed, the plaintiff, on behalf of the federal government, seeks treble damages plus civil penalties and attorneys’ fees. The plaintiff also has requested an award of 30% of any judgment plus expenses.

 

In the action by the former employee, discovery is complete but no trial date has been set. The parties have had initial discussions regarding their respective positions in the case; however, no resolution of this case has been reached or can be assured prior to the case proceeding to trial.

 

In a related matter, in February 2006, WPMC filed an arbitration claim seeking indemnification from us for certain costs and expenses incurred by it in connection with the case. In the action by WPMC, initial arbitration proceedings were commenced during the third quarter of fiscal 2006. During September 2007, the parties to this matter agreed to place the arbitration on hold for an indefinite period.

 

We believe that we have conducted our operations in full compliance with applicable statutory requirements and that we have meritorious defenses to the claims made in the case and the related arbitration proceeding, and intend to contest the claims vigorously. Nevertheless, it is possible that resolution of these legal matters could have a material adverse effect on our consolidated results of operations in a particular financial reporting period. We believe that we will continue to incur legal expenses associated with the defense of these matters which may be material to our consolidated results of operations in a particular financial reporting period. However, we believe that any resolution of this case and all related matters will not have a material effect on our liquidity or financial condition.

 

We are also subject to other claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against us, individually or in the aggregate, will not have a material adverse impact on our financial position, our results of operations, or our cash flows, these matters are subject to inherent uncertainties, and management’s view of these matters may change in the future.

 

(8)

Comprehensive Income

 

Comprehensive income, net of income taxes, was $10.5 million and $11.0 million for the three months ended February 29, 2008 and February 28, 2007, respectively and $20.7 million and $22.8 million for the six months ended February 29, 2008 and February 28, 2007, respectively.

 

 

 

13

 


 

(9)

Share Repurchases

 

The following table contains information for shares of our Common Stock that we repurchased during the second quarter of fiscal 2008:

 

Period

 

 

Total Number of Shares Purchased

 

 

 

Average Price Paid per Share

 

 

 

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)

 

 

 

Maximum Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 1 through 31

 

 

2,205

 

 

 

 

$59.92

 

 

 

128,788

 

 

 

 

$94,213,762

 

January 1 through 31

 

 

16,500

 

 

 

 

$59.17

 

 

 

145,288

 

 

 

 

$93,237,467

 

February 1 through 29

 

 

73,750

 

 

 

 

$47.61

 

 

 

219,038

 

 

 

 

$89,726,178

 

Total

 

 

92,455

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) All share repurchases between December 1, 2007 and February 29, 2008 were made pursuant to a share repurchase program authorized by the Company’s Board of Directors and publicly announced on July 5, 2007, which allows for the repurchase of up to $100 million of our common stock from time to time in the open market or in privately negotiated transactions through July 5, 2009.

 

(10)

Earnings Per Share

 

The following is a reconciliation of the numerator and denominator of basic and diluted earnings per share for the three and six months ended February 29, 2008 and February 28, 2007:

 

(In 000s, except per share data)

 

Three Months

 

Three Months

 

 

Six Months

 

Six Months

 

 

 

Ended

 

Ended

 

 

Ended

 

Ended

 

 

 

February 29,

 

February 28,

 

 

February 29,

 

February 28,

 

 

 

2008

 

2007

 

 

2008

 

2007

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income - numerator for basic earnings per share

 

$

12,454

 

$

11,024

 

 

$

23,637

 

$

22,858

 

Effect of dilutive securities

 

 

 

 

 

 

 

 

 

 

Numerator for diluted earnings per share

 

$

12,454

 

$

11,024

 

 

$

23,637

 

$

22,858

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used for basic earnings per share

 

 

36,031

 

 

34,958

 

 

 

35,873

 

 

34,792

 

Effect of dilutive stock options and restricted stock units outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-qualified stock options

 

 

1,726

 

 

1,922

 

 

 

1,786

 

 

1,936

 

Restricted stock units

 

 

154

 

 

55

 

 

 

142

 

 

35

 

Shares used for diluted earnings per share

 

 

37,911

 

 

36,935

 

 

 

37,801

 

 

36,763

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.35

 

$

0.32

 

 

$

0.66

 

$

0.66

 

Diluted

 

$

0.33

 

$

0.30

 

 

$

0.63

 

$

0.62

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dilutive securities outstanding not included in the computation of earnings per share because their

 

 

 

 

 

 

 

 

 

 

 

 

 

 

effect is antidilutive:

 

 

580

 

 

1,139

 

 

 

498

 

 

1,112

 

 

14

 


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Overview

 

Founded in 1981, Healthways, Inc. (the “Company”) provides specialized, comprehensive Health and Care Support SM solutions to help people maintain or improve their health and, as a result, reduce both direct healthcare costs and the costs of health-related lost productivity.

 

Designed to provide highly specific and personalized interventions for each individual in a population, irrespective of health status, age, or payor, our evidence-based services are made available to consumers by phone, mail, internet, and face-to-face interactions. To expand our Health Support offerings, on December 1, 2006, we acquired Axia Health Management, Inc. (“Axia”), a national provider of health and wellness programs.

 

We deliver our programs to customers, which include health plans, governments, employers, and hospitals, in all 50 states, the District of Columbia, and Puerto Rico. In January 2008, we also began delivering our Health and Care Support programs to a statutory health insurance company in Germany. Our services include:

 

 

fostering wellness and disease prevention through total population screening, health risk assessments, and supportive interventions;

 

providing access to health improvement programs such as fitness, weight management, complementary and alternative medicine and smoking cessation;

 

promoting the reduction of lifestyle behaviors that lead to poor health or chronic conditions;

 

providing educational materials and personal interactions with highly trained nurses and other healthcare professionals that are designed to create and sustain healthier behaviors to members with chronic conditions;

 

incorporating current evidence-based clinical guidelines into interventions to optimize patient health outcomes;

 

developing Care Support plans and motivating members to set attainable goals for themselves;

 

providing local market resources to address acute episodic interventions; and

 

coordinating members’ care with their healthcare providers.

 

Our programs focus on prevention, education, physical fitness, health coaching, behavior change and evidence-based interventions to drive adherence to proven standards of care, medication regimens and physicians’ plans of care. The programs are designed to support better health and assist in providing more effective care, which we believe will optimize the health status of member populations and reduce both the short-term and long-term direct healthcare costs for participants, including the costs of health-related lost productivity.

 

Health and Care Support services enable health plans and employers to reach and engage everyone in their covered populations through interventions that are both sensitive to and specific to each individual’s health risks and needs. Health Support products are designed to motivate people to make positive lifestyle changes and accomplish individual goals, such as becoming more physically active through the Healthways SilverSneakers® Fitness Program, staying fit using on-line tools and a vast network of fitness centers, and quitting smoking through an on-line smoking cessation community, QuitNet®. The Care Support product line includes programs for people with chronic diseases or persistent conditions, including diabetes, coronary artery disease, heart failure, asthma, chronic

 

15

 


obstructive pulmonary disease, end-stage renal disease, cancer, chronic kidney disease, depression, high-risk obesity, metabolic syndrome, acid-related stomach disorders, atrial fibrillation, decubitus ulcer, fibromyalgia, hepatitis C, inflammatory bowel disease, irritable bowel syndrome, low-back pain, osteoarthritis, osteoporosis, and urinary incontinence. We also provide high-risk care management through our StatusOne® product for members at risk for hospitalization due to complex conditions. We believe that creating real and sustainable behavior change generates measurable long-term cost savings.

 

Predicated on the fundamental belief that healthier people cost less, Healthways’ programs are designed to help keep healthy individuals healthy, mitigate and delay the progression to disease associated with family or lifestyle risk factors, and promote the best possible health habits for those who are already affected by disease. At the same time, we recognize that each individual plays a variety of roles in his or her pursuit of health, often simultaneously. By providing the full spectrum of Health and Care Support services to meet each individual’s needs, we believe that our interventions can be delivered both at scale and in a manner that reflects the unique needs of each consumer over time. Further, Healthways’ extensive and fully accredited complementary and alternative provider network offers convenient access to the significant number of individuals who seek health services outside of the traditional healthcare system.            

 

Highlights of Performance for the Three and Six Months Ended February 29, 2008

 

 

Revenues for the three months ended February 29, 2008 increased 11.7% over the three months ended February 28, 2007. Revenues for the six months ended February 29, 2008, which included six months of operations related to the acquisition of Axia on December 1, 2006, increased 27.9% over the six months ended February 28, 2007.

 

Net income for the three months ended February 29, 2008 increased 13.0% over the three months ended February 28, 2007. Net income for the six months ended February 29, 2008, which included six months of operations related to the acquisition of Axia, increased 3.4% over the six months ended February 28, 2007.               

 

Forward-Looking Statements

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements, which are based upon current expectations and involve a number of risks and uncertainties. Forward-looking statements include all statements that do not relate solely to historical or current facts, and can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” or “continue.” In order for us to use the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, we caution you that the following important factors, among others, may affect these forward-looking statements. Consequently, actual operations and results may differ materially from those expressed in the forward-looking statements. The important factors include but are not limited to:

 

 

our ability to sign and implement new contracts for Health and Care Support solutions;

 

our ability to accurately forecast performance and the timing of revenue recognition under the terms of our contracts with customers and/or our Cooperative Agreement with the Centers for Medicare & Medicaid Services (“CMS”) ahead of data collection and reconciliation in order to provide forward-looking guidance;

 

the effect of any new or proposed legislation, regulations and interpretations relating to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, including the potential expansion to Phase II for Medicare Health Support programs;

 

16

 


 

our ability to effect the financial, clinical, and satisfaction outcomes under our Cooperative Agreement with CMS and reach mutual agreement with CMS with respect to results necessary to achieve success under Phase I of Medicare Health Support;

 

our ability to anticipate the rate of market acceptance of Health and Care Support solutions and the individual market dynamics in potential international markets;

 

our ability to accurately forecast the costs necessary to implement our strategy of establishing a presence in these markets;

 

the risks associated with foreign currency exchange rate fluctuations and our ability to hedge against such fluctuations;

 

the potential adverse effects of additional regulatory requirements imposed by foreign governments and other regulatory bodies;

 

our ability to effectively manage any growth that we might experience;

 

our ability to retain existing health plan customers if they decide to take programs in-house or are acquired by other health plans which already have or are not interested in Health and Care Support programs;

 

the risks associated with a significant concentration of our revenues with a limited number of customers;

 

our ability to effect cost savings and clinical outcomes improvements under Health and Care Support contracts and reach mutual agreement with customers with respect to cost savings, or to effect such savings and improvements within the time frames contemplated by us;

 

our ability to recognize estimated annualized revenue in backlog in the manner and within the timeframe we expect, which is based on certain estimates regarding the implementation of our services;

 

our ability and/or the ability of our customers to enroll participants in our Health and Care Support programs in a manner and within the timeframe anticipated by us;

 

our ability to collect contractually earned performance incentive bonuses;

 

the ability of our customers and/or CMS to provide timely and accurate data that is essential to the operation and measurement of our performance under the terms of our contracts;

 

our ability to favorably resolve contract billing and interpretation issues with our customers;

 

increased leverage incurred in conjunction with the acquisition of Axia and our ability to service our debt and make principal and interest payments as those payments become due;

 

our ability to integrate the operations and technology platforms of Axia and other acquired businesses or technologies into our business;

 

our ability to develop new products and deliver outcomes on those products, including those anticipated from our strategic relationship with Medco, Inc.;

 

our ability to effectively integrate new technologies and approaches, such as those encompassed in our Health and Care Support initiatives or otherwise licensed or acquired by us, into our Health and Care Support platform;

 

our ability to renew and/or maintain contracts with our customers under existing terms or restructure these contracts on terms that would not have a material negative impact on our results of operations;

 

our ability to implement our Health and Care Support strategy within expected cost estimates;

 

our ability to obtain adequate financing to provide the capital that may be necessary to support the growth of our operations and to support or guarantee our performance under new contracts;

 

unusual and unforeseen patterns of healthcare utilization by individuals with diabetes, cardiac, respiratory and/or other diseases or conditions for which we provide services;

 

the ability of our customers to maintain the number of covered lives enrolled in the plans during the terms of our agreements;

 

our ability to attract and/or retain and effectively manage the employees required to implement our agreements;

 

the impact of litigation involving us and/or our subsidiaries;

 

17

 


 

the impact of future state, federal and international health care and other applicable legislation and regulations on our ability to deliver our services and on the financial health of our customers and their willingness to purchase our services;

 

current geopolitical turmoil and the continuing threat of domestic or international terrorism;

 

general worldwide and domestic economic conditions and stock market volatility; and

 

other risks detailed in our other filings with the Securities and Exchange Commission.

 

We undertake no obligation to update or revise any such forward-looking statements.

 

Customer Contracts

 

Contract Terms

 

We generally determine our contract fees by multiplying a contractually negotiated rate per member per month (“PMPM”) by the number of members covered by our services during the month. We typically set the PMPM rates during contract negotiations with customers based on the value we expect our programs to create and a sharing of that value between the customer and the Company. In some contracts, the PMPM rates may differ between a customer’s lines of business [e.g. Preferred Provider Organizations (“PPO”), Health Maintenance Organizations (“HMO”), Medicare Advantage]. In addition, some of our services are billed on a fee for service basis.

 

Our contracts generally range from three to five years with provisions for subsequent renewal; contracts with self-insured employers, either directly or through their health plans, typically have one-year terms. Some contracts allow the customer to terminate early.

 

Some of our contracts provide that a portion (up to 100%) of our fees may be refundable to the customer (“performance-based”) if our programs do not achieve, when compared to a baseline year, a targeted percentage reduction in the customer’s healthcare costs and selected clinical and/or other criteria that focus on improving the health of the members. Approximately 3% of revenues recorded during the six months ended February 29, 2008 were performance-based and were subject to final reconciliation as of February 29, 2008. We anticipate that this percentage will fluctuate due to the level of performance-based fees in new contracts, revenue recognition associated with performance-based fees, and the timing of data reconciliation, which varies according to contract terms. A limited number of contracts also provide opportunities for us to receive incentive bonuses in excess of the contractual PMPM rate if we exceed contractual performance targets.

 

We are currently participating in a Medicare Health Support pilot awarded under the Chronic Care Improvement Program authorized by the Medicare Modernization Act of 2003. The pilot is scheduled to operate for 36 months but may be terminated by either party with six months written notice. We began operating this pilot in August 2005 to serve 20,000 Medicare fee-for-service beneficiaries in Maryland and the District of Columbia. All fees under this pilot are performance-based. The pilot is for complex diabetes and congestive heart failure disease management services and, while operationally similar to our programs for commercial and Medicare Advantage health plan populations, has been modified for the special needs and conditions of this population. In addition, we began serving 20,000 beneficiaries in Georgia in September 2005 in collaboration with CIGNA HealthCare, Inc (“CIGNA”). CIGNA terminated its Chronic Care Improvement Program Cooperative Agreement with CMS effective January 14, 2008. The majority of our fees under our contract with CIGNA were performance-based.

 

In June 2006, we signed an amendment to our cooperative agreement with CMS for our Medicare Health Support stand-alone pilot in Maryland and the District of Columbia, which, among other things,

 

18

 


enabled us to provide congestive heart failure programs to approximately 4,500 additional Medicare fee-for-service beneficiaries for two years beginning on August 1, 2006 (the “refresh population”). All fees for the refresh population are performance-based.

 

Technology

 

Our customer contracts require sophisticated analytical, data management, Internet and computer-telephony solutions based on state-of-the-art technology. These solutions help us deliver Health and Care Support services to large populations within our customer base. Our predictive modeling capabilities allow us to identify and stratify those participants who are most at risk for an adverse health event. We incorporate behavior-change science with consumer-friendly interactions such as face-to-face, telephonic, print materials and web portals to facilitate consumer preferences for engagement and convenience. Sophisticated data analytical and reporting solutions are used to validate the impact of our programs on clinical and financial outcomes. We continue to invest heavily in technology and are continually expanding and improving our proprietary clinical, data management, and reporting systems to continue to meet the information management requirements of our Health and Care Support services.

 

Contract Revenues

 

Our contract revenues depend on the contractual terms we establish and maintain with customers to provide Health and Care Support services to their members. Some contracts allow the customer to terminate early. Restructurings and possible terminations at, or prior to, renewal could have a material negative impact on our results of operations and financial condition.

 

Approximately 21% of our revenues for the three and six months ended February 29, 2008 were derived from one customer. The loss of this customer or any other large customer or a reduction in the profitability of a contract with any large customer would have a material negative impact on our results of operations, cash flows, and financial condition.

 

Domestic Commercial Billed Lives and Domestic Commercial Available Lives

 

The number of domestic commercial available lives and domestic commercial billed lives as of February 29, 2008 and February 28, 2007 were as follows:

 

 

 

February 29,

 

February 28,

 

(In 000s)

 

2008

 

2007

 

Domestic commercial available lives (1)

 

187,500

 

184,800

 

Domestic commercial billed lives

 

26,400

 

26,400

 

 

(1) Estimated based on the Atlantic Information Services, Inc. (AIS) Directory of Health Plans and publicly available information.

 

Backlog

 

Backlog represents the estimated annualized revenue at target performance for business awarded but not yet started at February 29, 2008. Annualized revenue in backlog as of February 29, 2008 and February 28, 2007 was as follows:

 

 

 

February 29,

 

February 28,

 

(In 000s)

 

2008

 

2007

 

Annualized revenue in backlog

 

$

37,557

 

$

8,383

 

 

 

19

 


 

We continue to see increasing demand for our Health and Care Support services from self-insured employer accounts, most of which are contracted through the Administrative Services Only (ASO) line of business with our health plan customers and for which our health plan customers do not assume medical cost risk but provide primarily administrative claim and health network access services. Signed contracts between these self-insured employers and our health plan customers are incorporated in our contracts with our health plan customers, and these program-eligible members are included in the domestic commercial available and billed lives or in the annualized revenue in backlog reported in the table above, as appropriate.

 

Business Strategy

 

Our primary strategy is to optimize the health of entire populations as well as the quality and affordability of healthcare through our Health and Care Support solutions both domestically and internationally, thereby creating value for individuals, health plans, governments, and employers. We plan to continue using our scalable state-of-the-art call centers, medical information content, behavior change processes and techniques, strategic relationships, health provider networks and proprietary technologies to gain a competitive advantage in delivering our Health and Care Support services.

 

We expect to continue adding and enhancing solutions to extend our reach and effectiveness for entire populations. The flexibility of our programs allows customers to enter the Health and Care Support market at the level of services that they deem appropriate for their organization. Customers may select from a single Health or Care Support program to a total-population approach, in which all members of the customer’s population are eligible to receive the benefit of our programs.

 

We deliver programs that engage consumers in their health. We believe that we can achieve health improvements and generate significant cost savings by addressing consumer and customer needs for effective programs that support the individual throughout his or her lifetime.

 

We anticipate that we will continue to enhance and expand our Health and Care Support capabilities, pursue opportunities in domestic government and international markets, and enhance our information technology support. We may add some of these new capabilities and technologies through internal development, strategic alliances with other entities and/or through selective acquisitions or investments.

 

Critical Accounting Policies

 

We describe our accounting policies in Note 1 of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2007. We prepare the consolidated financial statements in conformity with U.S. generally accepted accounting principles, which require us to make estimates and judgments that affect the reported amounts of assets and liabilities and related disclosures at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.

 

We believe the following accounting policies are the most critical in understanding the estimates and judgments that are involved in preparing our financial statements and the uncertainties that could impact our results of operations, financial condition and cash flows.

 

 

 

20

 


Revenue Recognition

 

We generally determine our contract fees by multiplying a contractually negotiated rate per member per month (“PMPM”) by the number of members covered by our services during the month. We typically set the PMPM rates during contract negotiations with customers based on the value we expect our programs to create and a sharing of that value between the customer and the Company. In some contracts, the PMPM rates may differ between a customer’s lines of business (e.g., PPO, HMO, Medicare Advantage). In addition, some of our services are billed on a fee for service basis.

 

Some of our contracts provide that a portion (up to 100%) of our fees may be refundable to the customer (“performance-based”) if our programs do not achieve, when compared to a baseline year, a targeted percentage reduction in the customer’s healthcare costs and selected clinical and/or other criteria that focus on improving the health of the members. Approximately 3% of revenues recorded during the six months ended February 29, 2008 were performance-based and were subject to final reconciliation as of February 29, 2008. We anticipate that this percentage will fluctuate due to the level of performance-based fees in new contracts, revenue recognition associated with performance-based fees, and the timing of data reconciliation, which varies according to contract terms. A limited number of contracts also provide opportunities for us to receive incentive bonuses in excess of the contractual PMPM rate if we exceed contractual performance targets.

 

We generally bill our customers each month for the entire amount of the fees contractually due for the prior month’s enrollment, which typically includes the amount, if any, that is performance-based and may be subject to refund should we not meet performance targets. Deferred revenues can arise from contracts which permit upfront billing and collection of fees covering the entire contractual service period, generally 12 months. Contractually, we cannot bill for any incentive bonus until after contract settlement. Fees for service are typically billed in the month after the services are provided.

 

We recognize revenue as follows: 1) we recognize the fixed portion of PMPM fees and fees for service as revenue during the period we perform our services; 2) we recognize the performance-based portion of the monthly fees based on the most recent assessment of our performance, which represents the amount that the customer would legally be obligated to pay if the contract were terminated as of the latest balance sheet date; and 3) we recognize additional incentive bonuses based on the most recent assessment of our performance, to the extent we consider such amounts collectible.

 

We assess our level of performance for our contracts based on medical claims and other data that the customer is contractually required to supply. A minimum of four to six months’ of data is typically required for us to measure performance. In assessing our performance, we may include estimates such as medical claims incurred but not reported and a medical cost trend compared to a baseline year. In addition, we may also provide contractual reserves, when appropriate, for billing adjustments at contract reconciliation.

 

All of the fees under the Medicare Health Support pilot in which we are currently participating are performance-based. Our current cooperative agreement requires that, by the end of the third year, we achieve a cumulative net savings (total savings for the intervention population as compared to the control group less fees received from CMS) of 5.0%. The cumulative net savings targets are lower at the beginning of the pilots and increase in gradual increments, ending with a cumulative net savings target of 5.0% at the end of the pilots. Under the amendment to our agreement, we began serving a “refresh population” of approximately 4,500 beneficiaries on August 1, 2006, which will be measured as a separate cohort for two years, by the end of which the program is required to achieve a 2.5% cumulative net savings when compared to a new control cohort. We have been advised that the Office of Management and Budget has approved a request from CMS to lower the savings target for the Medicare Health Support pilots from 5.0% net savings to

 

21

 


budget neutrality (savings greater than or equal to fees). We have not yet reached agreement with CMS as to how the new savings target will be implemented. Although we receive the medical claims and other data associated with the intervention group under these pilots on a monthly basis, we assess our performance against the control group under these pilots based on quarterly summary performance reports received from CMS’ independent financial reconciliation contractor. As of February 29, 2008, contract billings in excess of earned revenue related to the Medicare Health Support pilots totaled $66.8 million.

 

If data is insufficient or incomplete to measure performance, or interim performance measures indicate that we are not meeting performance targets, we do not recognize performance-based fees subject to refund as revenues but instead record them in a current liability account “contract billings in excess of earned revenue.” Only in the event we do not meet performance levels by the end of the measurement period, typically one year, are we contractually obligated to refund some or all of the performance-based fees. We would only reverse revenues that we had already recognized if performance to date in the measurement period, previously above targeted levels, subsequently dropped below targeted levels. Historically, any such adjustments have been immaterial to our financial condition and results of operations.

 

During the settlement process under a contract, which generally occurs six to eight months after the end of a contract year, we settle any performance-based fees and reconcile healthcare claims and clinical data. As of February 29, 2008, performance-based fees that have not yet been settled with our customers but that have been recognized as revenue in the current and prior years totaled approximately $39.8 million. Of this amount, $12.6 million was based on calculations which include estimates such as medical claims incurred but not reported and/or the customer’s medical cost trend compared to a baseline year, while $27.2 million was based entirely on actual data received from our customers. Data reconciliation differences, for which we provide contractual allowances until we reach agreement with respect to identified issues, can arise between the customer and us due to customer data deficiencies, omissions, and/or data discrepancies.

 

Performance-related adjustments (including any amounts recorded as revenue that were ultimately refunded), changes in estimates, data reconciliation differences, or adjustments to incentive bonuses may cause us to recognize or reverse revenue in a current fiscal year that pertains to services provided during a prior fiscal year. During the six months ended February 29, 2008, we recognized a net increase in revenue of approximately $1.3 million that related to services provided prior to fiscal 2008.

 

Impairment of Intangible Assets and Goodwill

 

In accordance with SFAS No. 142 “Goodwill and Other Intangible Assets,” we review goodwill for impairment on an annual basis or more frequently whenever events or circumstances indicate that the carrying value may not be recoverable.

 

If we determine that the carrying value of goodwill is impaired based upon an impairment review, we calculate any impairment using a fair-value-based goodwill impairment test as required by SFAS No. 142. Fair value is the amount at which the asset could be bought or sold in a current transaction between two willing parties. We estimate fair value using a number of techniques, including quoted market prices or valuations by third parties, present value techniques based on estimates of cash flows, or multiples of earnings or revenues performance measures.

 

We amortize other identifiable intangible assets, such as acquired technologies and customer contracts, on the straight-line method over their estimated useful lives, except for certain trade names, which have an indefinite life and are not subject to amortization. We review intangible assets not subject to amortization on an annual basis or more frequently whenever events or circumstances indicate that the

 

22

 


assets might be impaired. We assess the potential impairment of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying values may not be recoverable.

 

If we determine that the carrying value of other identifiable intangible assets may not be recoverable, we calculate any impairment using an estimate of the asset’s fair value based on the projected net cash flows expected to result from that asset, including eventual disposition.

 

Future events could cause us to conclude that impairment indicators exist and that goodwill and/or other intangible assets associated with our acquired businesses are impaired. Any resulting impairment loss could have a material adverse impact on our financial condition and results of operations.

 

Share-Based Compensation

 

In accordance with SFAS No. 123(R), we measure and recognize compensation expense for all share-based payment awards based on estimated fair values at the date of grant. Determining the fair value of share-based awards at the grant date requires judgment in developing assumptions, which involve a number of variables. These variables include, but are not limited to, the expected stock price volatility over the term of the awards and expected stock option exercise behavior. In addition, we also use judgment in estimating the number of share-based awards that are expected to be forfeited. We contract with a third party to assist in developing the assumptions used in estimating the fair values of stock options.

 

Results of Operations

 

The following table shows the components of the statements of operations for the three and six months ended February 29, 2008 and February 28, 2007 expressed as a percentage of revenues.

 

 

 

 

 

Three Months Ended

 

 

 

Six Months Ended

 

 

 

 

 

February 29/28,

 

 

 

February 29/28,

 

 

 

 

 

2008

 

2007

 

 

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

100.0

%

100.0

%

 

 

100.0

%

100.0

%

Cost of services (exclusive of depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

and amortization included below)

 

 

 

70.0

%

68.0

%

 

 

70.3

%

67.3

%

Selling, general and administrative expenses

 

 

 

9.4

%

10.3

%

 

 

9.5

%

10.5

%

Depreciation and amortization

 

 

 

5.9

%

6.4

%

 

 

5.9

%

6.2

%

Operating income (1)

 

 

 

14.6

%

15.3

%

 

 

14.2

%

16.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

 

2.8

%

3.9

%

 

 

2.9

%

2.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

 

 

11.8

%

11.4

%

 

 

11.3

%

13.7

%

Income tax expense

 

 

 

4.9

%

4.5

%

 

 

4.7

%

5.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (1)

 

 

 

7.0

%

6.9

%

 

 

6.7

%

8.2

%

 

(1) Figures may not add due to rounding.

 

 

23

 


Revenues

 

Revenues for the three months ended February 29, 2008 increased 11.7% over revenues for the three months ended February 28, 2007, primarily due to the following:

 

 

the addition of new programs or the expansion of existing programs into additional populations with existing customers since the beginning of the second quarter of fiscal 2007;

 

increased membership in customers’ existing programs; and

 

the commencement of new contracts since the beginning of the second quarter of fiscal 2007.

 

These increases were partially offset by decreases in revenues for the three months ended February 29, 2008 compared to the three months ended February 28, 2007 primarily due to contract terminations and reductions in the scope of our services with certain customers.

 

Revenues for the six months ended February 29, 2008 increased 27.9% over revenues for the six months ended February 28, 2007, primarily due to the following:

 

 

revenues attributable to the acquisition of Axia on December 1, 2006;

 

increased membership in customers’ existing programs; and

 

the addition of new programs or the expansion of existing programs into additional populations with existing customers since the beginning of fiscal 2007.

 

These increases were partially offset by decreases in revenues for the six months ended February 29, 2008 compared to the six months ended February 28, 2007 primarily due to contract terminations and reductions in the scope of our services with certain customers.

 

We anticipate that, despite the aforementioned contract terminations and contract scope reductions, revenues for the remainder of fiscal 2008 will increase over fiscal 2007 revenues primarily due to increasing demand for our Health and Care Support services from both existing and new customers and business awarded during fiscal 2007 and fiscal 2008 which has not yet started.

 

Cost of Services

 

Cost of services (excluding depreciation and amortization) as a percentage of revenues increased to 70.0% for the three months ended February 29, 2008 compared to 68.0% for the same period in fiscal 2007. The increase is primarily due to the following:

 

 

costs related to the opening of three new call centers, including the initial operating costs related to hiring and training, as well as the resulting lower capacity utilization during the early months of operations;

 

increased member utilization of fitness centers for contracts for which we receive a fixed fee per member; and

 

an increased portion of our revenue growth generated by fitness center programs, which typically have a higher cost of services as a percentage of revenue than our other programs.

 

These increases were partially offset by decreases in cost of services as a percentage of revenues for the three months ended February 29, 2008 compared to the three months ended February 28, 2007 primarily due to the following:

 

 

decreased costs related to the Medicare Health Support pilot in which we participated in collaboration with CIGNA, which CIGNA terminated effective January 14, 2008; and

 

24

 


 

a decrease in the level of employee bonus provision during the three months ended February 29, 2008 compared to the three months ended February 28, 2007.

 

Cost of services (excluding depreciation and amortization) as a percentage of revenues for the six months ended February 29, 2008 increased to 70.3% compared to 67.3% for the same period in fiscal 2007. The increase is primarily due to the following:

 

 

an increased portion of our revenue growth generated by fitness center programs, which typically have a higher cost of services as a percentage of revenue than our other programs;

 

costs related to the opening of four new call centers, including the initial operating costs related to hiring and training, as well as the resulting lower capacity utilization during the early months of operations; and

 

the acquisition of Axia on December 1, 2006, which has a higher cost of services as a percentage of revenue.

 

These increases were partially offset by decreases in cost of services as a percentage of revenues for the six months ended February 29, 2008 compared to the six months ended February 28, 2007, primarily due to decreased costs related to the Medicare Health Support pilot in which we participated in collaboration with CIGNA, which CIGNA terminated effective January 14, 2008.

 

We anticipate that cost of services for the remainder of fiscal 2008 will increase over fiscal 2007 primarily as a result of expenses associated with increases in operating staff required for expected increases in demand for our services, increases in indirect staff costs associated with the continuing development and implementation of our Health and Care Support services, and increases in information technology and other support staff and costs.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses as a percentage of revenues decreased to 9.4% and 9.5% for the three and six months ended February 29, 2008 from 10.3% and 10.5%, respectively, for three and six months ended February 28, 2007, primarily due to efficiencies from the integration of the Axia acquisition and the resignation of one of our executive officers in December 2007.

 

We anticipate that selling, general and administrative expenses for the remainder of fiscal 2008 will increase over fiscal 2007 primarily due to anticipated investments in international initiatives, increases in selling and general administrative costs in support of our existing and anticipated new and expanded contracts, and costs related to relocating to and operating our new corporate headquarters.

 

Depreciation and Amortization

 

Depreciation and amortization expense for the six months ended February 29, 2008 increased 23.3% compared to the same period in fiscal 2007 primarily due to depreciation and amortization expense associated with the depreciable assets and identifiable intangible assets recorded in connection with the Axia acquisition on December 1, 2006.

 

We anticipate that depreciation and amortization expense for the remainder of fiscal 2008 will increase over fiscal 2007 primarily as a result of additional capital expenditures made during fiscal 2008

 

25

 


associated with our new corporate headquarters, the opening of four new call centers, and growth and improvement in our information technology capabilities .

 

Interest Expense

 

Interest expense for the three months ended February 29, 2008 decreased $1.3 million compared to the three months ended February 28, 2007, primarily as a result of repayments on outstanding borrowings under the Third Amended Credit Agreement. Interest expense for the six months ended February 29, 2008 increased $3.8 million compared to the six months ended February 28, 2007, primarily due to borrowings under the Third Amended Credit Agreement.

 

We anticipate that interest expense for the remainder of fiscal 2008 will decrease over fiscal 2007 primarily as a result of an expected decrease in interest rates on outstanding borrowings under the Third Amended Credit Agreement.

 

Income Tax Expense

 

Our effective tax rate increased to 41.2% and 41.1% for the three and six months ended February 29, 2008 compared to 39.6% and 40.0% for the three and six months ended February 28, 2007 primarily due to increased expenses incurred in international initiatives and the lack of tax benefit on certain of these expenses, as well as the impact of interest accruals related to unrecognized tax benefits included in our income tax provision. The differences between the statutory federal income tax rate of 35.0% and our effective tax rate are due primarily to the impact of state income taxes, the lack of tax benefit on certain expenses incurred in international initiatives, tax interest accruals, and certain non-deductible expenses for income tax purposes.

 

We anticipate that our effective tax rate for the remainder of fiscal 2008 will not change significantly; however, we continue to evaluate the impact of our growth on our geographic mix of earnings and overall state tax rate.

 

Liquidity and Capital Resources

 

Operating activities for the six months ended February 29, 2008 generated cash of $50.0 million compared to $24.6 million for the same period in fiscal 2007. The increase in operating cash flow resulted primarily from the following:

 

 

a lower employee bonus payment during the six months ended February 29, 2008 compared to the six months ended February 28, 2007;

 

a decrease in income tax payments during the six months ended February 29, 2008 compared to the six months ended February 28, 2007, due to 1) increased final tax payments in fiscal 2007 pertaining to the previous fiscal year and 2) a lower level of employee stock option exercises during the six months ended February 28, 2007; and

 

lease incentives received during the six months ended February 29, 2008, primarily related to our new corporate headquarters.

 

These increases were partially offset by a decrease in operating cash flow during the six months ended February 29, 2008 compared to the six months ended February 28, 2007, primarily due to an increase in days’ sales outstanding in accounts receivable to 55 days at February 29, 2008 from 53 days at February 28, 2007.

 

26

 


Investing activities during the six months ended February 29, 2008 used $46.1 million in cash, which primarily consisted of purchases of property and equipment associated with our new corporate headquarters, information technology hardware and software, and new call centers.

 

Financing activities during the six months ended February 29, 2008 used $10.8 million in cash, primarily from repayments on borrowings under the Third Amended Credit Agreement and repurchases of our common stock, somewhat offset by proceeds from the exercise of stock options and the related tax benefit.

 

On December 1, 2006, we entered into the Third Amended Credit Agreement. The Third Amended Credit Agreement provides us with a $400.0 million revolving credit facility, including a swingline sub facility of $10.0 million and a $75.0 million sub facility for letters of credit, a $200.0 million term loan facility, and an uncommitted incremental accordion facility of $200.0 million. As of February 29, 2008, availability under our revolving credit facility totaled $317.9 million.

 

Revolving advances under the Third Amended Credit Agreement generally bear interest, at our option, at 1) LIBOR plus a spread of 0.875% to 1.750% or 2) the greater of the federal funds rate plus 0.5%, or the prime rate, plus a spread of 0.000% to 0.250%. Term loan borrowings bear interest, at our option, at 1) LIBOR plus 1.50% or 2) the greater of the federal funds rate plus 0.5%, or the prime rate. The Third Amended Credit Agreement also provides for a fee ranging between 0.150% and 0.300% of unused commitments. The Third Amended Credit Agreement is secured by guarantees from most of the Company’s domestic subsidiaries and by security interests in substantially all of the Company’s and such subsidiaries’ assets.

 

We are required to repay outstanding revolving loans on the revolving commitment termination date, which is December 1, 2011. We are required to repay term loans in quarterly principal installments aggregating $0.5 million each, which commenced on March 31, 2007, and the entire unpaid principal balance of the term loans is due and payable at maturity on December 1, 2013.

 

The Third Amended Credit Agreement contains various financial covenants, which require us to maintain, as defined, ratios or levels of (i) total funded debt to EBITDA, (ii) fixed charge coverage, and (iii) net worth. The Third Amended Credit Agreement also restricts the payment of dividends and limits the amount of repurchases of the Company’s common stock. As of February 29, 2008, we were in compliance with all of the covenant requirements of the Third Amended Credit Agreement.

 

On December 21, 2006, we entered into an amortizing interest rate swap agreement for the management of interest rate exposure. By entering into this interest rate swap agreement, we effectively converted $230.0 million of floating rate debt to a fixed obligation with an interest rate of 4.995%. The principal value of the swap arrangement amortizes over a 39-month period and terminates on March 31, 2010. In addition, we entered into a second interest rate swap agreement on December 11, 2007. By entering into this interest rate swap agreement, we effectively converted $40.0 million of floating rate debt to a fixed obligation with an interest rate of 3.987%. We currently believe that we meet the hedge accounting criteria under SFAS No. 133 in accounting for these interest rate swap agreements.

 

We believe that cash flows from operating activities, our available cash, and our expected available credit under the Third Amended Credit Agreement will continue to enable us to meet our contractual obligations and to fund the current level of growth in our operations for the foreseeable future. However, if expanding our operations requires significant additional financing resources, such as capital expenditures for technology improvements, additional call centers and/or letters of credit or other forms of financial assurance to guarantee our performance under the terms of new contracts, or if we are required to refund performance-based fees pursuant to contract terms, we may need to raise additional

 

27

 


capital by expanding our existing credit facility and/or issuing debt or equity. If we face a limited ability to arrange such financing, it may restrict our ability to expand our operations.

 

If contract development accelerates or acquisition opportunities arise that would expand our operations, we may need to issue additional debt or equity to provide the funding for these increased growth opportunities. We may also issue equity in connection with future acquisitions or strategic alliances. We cannot assure you that we would be able to issue additional debt or equity on terms that would be acceptable to us.

 

In July 2007, our Board of Directors authorized a share repurchase program which allows for the repurchase of up to $100 million of our common stock from time to time in the open market or in privately negotiated transactions through July 5, 2009. As of February 29, 2008, $89.7 million of our common stock is still subject to repurchase under this program.

 

Contractual Obligations

 

There were no material changes outside the ordinary course of our business in our contractual obligations from those reported at August 31, 2007 in our Annual Report on Form 10-K, except for a new perpetual license agreement and 25-year strategic relationship agreement that we entered into during the second quarter of fiscal 2008. We have total contractual cash obligations of $45.0 million related to these agreements, $25.0 million of which will occur ratably during the first five years of the agreements, and the remaining $20.0 million of which will occur ratably over the last 20 years of the agreements.

 

In addition to the above and as discussed in Note 4, we adopted the provisions of FIN No. 48 on September 1, 2007. Total unrecognized tax benefits as of September 1, 2007 were $11.1 million. We have classified the liability for unrecognized tax benefits as long-term in the consolidated balance sheet. Due to the uncertainties related to these tax positions, we are currently unable to determine when these unrecognized tax positions will result in obligations requiring future cash payments.

 

Recently Issued Accounting Standards

 

Fair Value Measurement

 

In September 2006 the FASB issued SFAS No. 157, “Fair Value Measurement,” which provides guidance for using fair value to measure assets and liabilities, including a fair value hierarchy that prioritizes the information used to develop fair value assumptions.  It also requires expanded disclosure about the extent to which companies measure assets and liabilities at fair value, the information used to measure fair value, and the effect of fair value measurements on earnings.  The standard applies whenever other standards require (or permit) assets or liabilities to be measured at fair value and does not expand the use of fair value in any new circumstances.  SFAS No. 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years.

 

In February 2008, the FASB issued FSP FAS No. 157-2, “Effective Date of FASB Statement No. 157”, which defers by one year the effective date of the provisions of SFAS No. 157 for non-recurring, nonfinancial assets and nonfinancial liabilities to fiscal years beginning after November 15, 2008. We do not expect the adoption of SFAS No. 157 to have a material impact on our financial position or results of operations.

 

 

 

28

 


Business Combinations

In December 2007, the FASB issued SFAS No. 141(R), “Business Combinations”. This statement expands the definition of a business and a business combination and generally requires the acquiring entity to recognize all of the assets and liabilities of the acquired business, regardless of the percentage ownership acquired, at their fair values. It also requires that contingent consideration and certain acquired contingencies be recorded at fair value on the acquisition date and that acquisition costs generally be expensed as incurred.

SFAS No. 141(R) is effective for fiscal years beginning after December 15, 2008. We have not yet completed our analysis of the impact that the implementation of SFAS No. 141(R) will have on our results of operations or financial condition.

Accounting for Uncertainty in Income Taxes

On September 1, 2007, we adopted the provisions of FIN No. 48, “Accounting for Uncertainty in Income Taxes - an interpretation of FASB Statement No. 109” (see Note 4). FIN No. 48 creates a single model to address uncertainty in income tax positions by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. It also provides guidance on derecognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and income tax disclosures. As a result of the adoption of FIN No. 48, we recorded a $0.7 million decrease to the beginning balance of retained earnings as a cumulative effect of a change in accounting principle.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are subject to market risk related to interest rate changes, primarily as a result of the Third Amended Credit Agreement, which bears interest based on floating rates. Revolving advances under the Third Amended Credit Agreement generally bear interest, at our option, at 1) LIBOR plus a spread of 0.875% to 1.750% or 2) the greater of the federal funds rate plus 0.5%, or the prime rate, plus a spread of 0.000% to 0.250%. Term loan borrowings bear interest, at our option, at 1) LIBOR plus 1.50% or 2) the greater of the federal funds rate plus 0.5%, or the prime rate.

 

In order to manage our interest rate exposure under the Third Amended Credit Agreement, we have entered into two interest rate swap agreements effectively converting $230.0 million and $40.0 million of floating rate debt to fixed obligations with interest rates of 4.995% and 3.987%, respectively.

 

A one-point interest rate change would have resulted in interest expense fluctuating approximately $0.4 million for the six months ended February 29, 2008.

 

As of February 29, 2008, as a result of our investment in international initiatives, we are also exposed to foreign currency exchange rate risks. Because a significant portion of these risks is economically hedged with currency options and forwards contracts and because our international initiatives are not yet material to our consolidated results of operations, a 10% change in foreign currency exchange rates would not have had a material impact on our results of operations or financial position for the six months ended February 29, 2008. We do not execute transactions or hold derivative financial instruments for trading purposes.

 

 

29

 


Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our chief executive officer and chief financial officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”)) as of February 29, 2008. Based on that evaluation, the chief executive officer and chief financial officer have concluded that our disclosure controls and procedures effectively and timely provide them with material information relating to the Company and its consolidated subsidiaries required to be disclosed in the reports the Company files or submits under the Exchange Act.

 

Changes in Internal Control over Financial Reporting

 

On December 1, 2006, we completed our acquisition of Axia. We continue to evaluate additional processes, information technology systems and other components of internal control over financial reporting resulting from the acquisition of Axia, and such evaluation will be reported in management’s annual assessment of internal control over financial reporting in our 2008 Annual Report on Form 10-K.

 

Excluding Axia, there have been no changes in our internal controls over financial reporting during the quarter ended February 29, 2008 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Part II

 

Item 1. Legal Proceedings

 

In June 1994, a former employee whom we dismissed in February 1994 filed a “whistle blower” action on behalf of the United States government. Subsequent to its review of this case, the federal government determined not to intervene in the litigation. The employee sued Healthways, Inc. and our wholly-owned subsidiary, American Healthways Services, Inc. (“AHSI”), as well as certain named and unnamed medical directors and one named client hospital, West Paces Medical Center (“WPMC”), and other unnamed client hospitals.

 

Healthways, Inc. has since been dismissed as a defendant; however, the case is still pending against AHSI before the United States District Court for the District of Columbia. In addition, WPMC has settled claims filed against it as part of a larger settlement agreement that WPMC’s parent organization, HCA Inc., reached with the United States government. The plaintiff has also dismissed its claims against the medical directors with prejudice, and on February 7, 2007 the court granted the plaintiff’s motion and dismissed all claims against all named medical directors.

 

The complaint alleges that AHSI, the client hospitals and the medical directors violated the federal False Claims Act by entering into certain arrangements that allegedly violated the federal anti-kickback statute and provisions of the Social Security Act prohibiting physician self-referrals. Although no specific monetary damage has been claimed, the plaintiff, on behalf of the federal government, seeks treble damages plus civil penalties and attorneys’ fees. The plaintiff also has requested an award of 30% of any judgment plus expenses.

 

In the action by the former employee, discovery is complete but no trial date has been set. The parties have had initial discussions regarding their respective positions in the case; however, no resolution of this case has been reached or can be assured prior to the case proceeding to trial.

 

30

 


 

In a related matter, in February 2006, WPMC filed an arbitration claim seeking indemnification from us for certain costs and expenses incurred by it in connection with the case. In the action by WPMC, initial arbitration proceedings were commenced during the third quarter of fiscal 2006. During September 2007, the parties to this matter agreed to place the arbitration on hold for an indefinite period.

 

We believe that we have conducted our operations in full compliance with applicable statutory requirements and that we have meritorious defenses to the claims made in the case and the related arbitration proceeding, and intend to contest the claims vigorously. Nevertheless, it is possible that resolution of these legal matters could have a material adverse effect on our consolidated results of operations in a particular financial reporting period. We believe that we will continue to incur legal expenses associated with the defense of these matters which may be material to our consolidated results of operations in a particular financial reporting period. However, we believe that any resolution of this case and all related matters will not have a material effect on our liquidity or financial condition.

 

We are also subject to other claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against us, individually or in the aggregate, will not have a material adverse impact on our financial position, our results of operations, or our cash flows, these matters are subject to inherent uncertainties, and management’s view of these matters may change in the future.

 

Item 1A. Risk Factors

 

 

Not Applicable.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

 

Not Applicable.

 

Item 3. Defaults Upon Senior Securities

 

 

Not Applicable.

 

Item 4. Submission of Matters to a Vote of Security Holders

 

 

(a)

  The Annual Meeting of Stockholders of Healthways, Inc. was held on February 14, 2008.


 

(b)

  The following proposals were voted upon at the Annual Meeting of Stockholders:

 

 

(i)

Nominations to elect Thomas G. Cigarran, Dr. C. Warren Neel, and John W. Ballantine as Directors of the Company. The results of the election of the above-mentioned nominees were as follows:

 

 

 

For

 

 

 

 

Withheld

 

Thomas G. Cigarran

 

32,403,781

 

 

 

 

1,735,262

 

C. Warren Neel

 

32,732,861

 

 

 

 

1,406,182

 

John W. Ballantine

 

33,784,030

 

 

 

 

355,013

 

 

 

(ii)

Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal 2008. The voting results were as follows:

 

31

 


 

For

 

 

 

Against

 

 

 

Abstain from Voting

 

33,891,692

 

 

 

56,694

 

 

 

190,657

 

 

 

(iii)

Amendment of the Company’s Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock from 75,000,000 to 120,000,000. The voting results of the above-mentioned amendment were as follows:

 

For

 

 

 

Against

 

 

 

Abstain from Voting

 

28,931,849

 

 

 

5,002,653

 

 

 

204,541

 

 

Item 5. Other Information

 

 

Not Applicable.

 

Item 6. Exhibits

 

 

(a)

Exhibits

 

32

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

Healthways, Inc.

 

 

 

 

(Registrant)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Date

April 8, 2008

 

By

/s/ Mary A. Chaput

 

 

 

Mary A. Chaput

 

 

 

 

Executive Vice President

 

 

 

 

Chief Financial Officer

 

 

 

 

(Principal Financial Officer)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Date

April 8, 2008

 

By

/s/ Alfred Lumsdaine

 

 

 

 

Alfred Lumsdaine

 

 

 

 

Senior Vice President and

 

 

 

 

Controller

 

 

 

 

(Principal Accounting Officer)

 

 

 

33

 

 

Exhibit 3.1

 

RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED OF

HEALTHWAYS, INC.

 

(Originally incorporated on September 2, 1981)

 

FIRST : The name of the corporation (hereinafter called the "Corporation") is Healthways, Inc.

 

SECOND : The address of the registered office of the Corporation in the State of Delaware is 1209 Orange Street, City of Wilmington, County of New Castle. The name of the registered agent of the Corporation at such address is The Corporation Trust Company.

 

THIRD : The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware.

 

FOURTH : The aggregate number of shares of capital stock the Corporation is authorized to issue is 125,000,000 shares, of which 120,000,000 shares shall be Common Stock, par value $.001 per share (the "Common Stock"), and 5,000,000 shares shall be preferred stock, par value $.001 per share (the "Preferred Stock"), of which 1,200,000 shares are designated as Series A Preferred Stock (the "Series A Preferred Stock").

 

The designations and the powers, preferences and relative, participating, optional or other rights of the capital stock and the qualifications, limitations or restrictions thereof are as follows:

 

A.

COMMON STOCK PROVISIONS

 

 

1.

Voting Rights .

 

Except as otherwise required by law or expressly provided herein, the holder of each share of Common Stock shall have one vote on each matter submitted to a vote of the stockholders of the Corporation.

 

 

2.

Dividend Rights .

 

Subject to the provisions of law, the holders of the Common Stock shall be entitled to receive dividends at such times and in such amounts as may be determined by the Board of Directors of the Corporation.

 

 

3.

Liquidation Rights .

 

In the event of any liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary, after payment or provision for payment of the debts and other liabilities of the Corporation and the preferential amounts to which the holders of any outstanding shares of

 


Preferred Stock shall be entitled upon dissolution, liquidation, or winding up, the holders of the Common Stock shall be entitled to share ratably in the remaining assets of the Corporation.

 

B.

PREFERRED STOCK PROVISIONS

 

 

1.

Designation .

 

The Board of Directors is authorized, subject to any limitations prescribed by law, to provide for the issuance of the shares of Preferred Stock in series, and by filing a certificate pursuant to the applicable law of the State of Delaware, to establish from time to time the number of shares to be included in each such series, and to fix the designation, powers, preferences, and rights of the shares of each such series and any qualifications, limitations or restrictions thereof. The number of authorized shares of Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the Common Stock without a vote of the holders of the Preferred Stock, or of any series thereof, unless a vote of any such holders is required pursuant to the certificate or certificates establishing the series of Preferred Stock.

 

 

2.

Liquidation Rights .

 

If upon any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the assets available for distribution to holders of shares of Preferred Stock of all series shall be insufficient to pay such holders the full preferential amount to which they are entitled, then such assets shall be distributed ratably among the shares of all series of Preferred Stock in accordance with the respective preferential amounts payable with respect thereto.

 

 

3.

Series A Preferred Stock .

 

Pursuant to the authority vested in the Board of Directors in accordance with the provisions of this Article Fourth of the Restated Certificate of Incorporation, the Board of Directors does hereby create, authorize and provide for the issuance of the Series A Preferred Stock out of the class of 5,000,000 shares of Preferred Stock, having the voting powers, designation, relative, participating, optional and other special rights, preferences, and qualifications, limitations and restrictions thereof that are set forth as follows:

 

(a)           Designation and Amount . The shares of such series shall be designated as Series A Preferred Stock ("Series A Preferred Stock") and the number of shares constituting such series shall be 750,000. Such number of shares may be adjusted by appropriate action of the Board of Directors.

 

(b)          Dividends and Distributions . Subject to the prior and superior rights of the holders of any shares of any other series of Preferred Stock or any other shares of Preferred Stock of the Corporation ranking prior and superior to the shares of Series A Preferred Stock with respect to dividends, each holder of one one-hundredth (1/100) of a share (a "Unit") of Series A Preferred Stock shall be entitled to receive, when, as and if declared by the Board of Directors out of funds legally available for that purpose, dividends at the same rate as dividends

 


are paid with respect to the Common Stock. In the event that the Corporation shall at any time after June 19, 2000 (the "Rights Dividend Declaration Date") (i) declare or pay any dividend on outstanding shares of Common Stock payable in shares of Common Stock; (ii) subdivide outstanding shares of Common Stock; or (iii) combine outstanding shares of Common Stock into a smaller number of shares, then in each such case the amount to which the holder of a Unit of Series A Preferred Stock was entitled immediately prior to such event pursuant to the preceding sentence shall be adjusted by multiplying such amount by a fraction the numerator of which shall be the number of shares of Common Stock that are outstanding immediately after such event and the denominator of which shall be the number of shares of Common Stock that were outstanding immediately prior to such event.

 

(c)           Voting Rights . The holders of Units of Series A Preferred Stock shall have the following voting rights:

 

(i)            Subject to the provision for adjustment hereinafter set forth, each Unit of Series A Preferred Stock shall entitle the holder thereof to one vote on all matters submitted to a vote of the stockholders of the Corporation. In the event the Corporation shall at any time after the Rights Dividend Declaration Date (i) declare any dividend on outstanding shares of Common Stock payable in shares of Common Stock; (ii) subdivide outstanding shares of Common Stock; or (iii) combine the outstanding shares of Common Stock into a smaller number of shares, then in each such case the number of votes per Unit to which holders of Units of Series A Preferred Stock were entitled immediately prior to such event shall be adjusted by multiplying such number by a fraction the numerator of which shall be the number of shares of Common Stock that are outstanding immediately after such event and the denominator of which shall be the number of shares of Common Stock that were outstanding immediately prior to such event.

 

(ii)        Except as otherwise provided herein or by law, the holders of Units of Series A Preferred Stock and the holders of shares of Common Stock shall vote together as one class on all matters submitted to a vote of stockholders of the Corporation.

 

(iii)         Except as set forth herein or required by law, holders of Units of Series A Preferred Stock shall have no special voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of shares of Common Stock as set forth herein) for the taking of any corporate action.

 

(d)          Reacquired Shares . Any Units of Series A Preferred Stock purchased or otherwise acquired by the Corporation in any manner whatsoever shall be retired and cancelled promptly after the acquisition thereof. All such Units shall, upon their cancellation, become authorized but unissued Units of Series A Preferred Stock to be created by resolution or resolutions of the Board of Directors, subject to the conditions and restrictions on issuance set forth herein.

 

(e)           Liquidation . Upon any liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary, the holders of Units of SeriesA Preferred Stock shall be entitled to share in any assets remaining ratably with the holders of the Common Stock. In the

 


event the Corporation shall at any time after the Rights Dividend Declaration Date (i) increase by way of stock split or similar transaction the number of outstanding shares of Common Stock; (ii) subdivide the outstanding shares of Common Stock; or (iii) combine the outstanding shares of Common Stock into a smaller number of shares, then in each such case the aggregate amount to which holders of Units of Series A Preferred Stock were entitled prior to such event shall be adjusted by multiplying such amount by a fraction, the numerator of which shall be the number of shares of Common Stock that are outstanding immediately after such event and the denominator of which shall be the number of shares of Common Stock that were outstanding immediately prior to such event.

 

(f)           Share Exchange, Merger, Etc. In case the Corporation shall enter into any share exchange, merger, combination or other transaction in which the shares of Common Stock are exchanged for or converted into other stock or securities, cash and/or any other property, then in any such case Units of Series A Preferred Stock shall at the same time be similarly exchanged for or converted into an amount per Unit (subject to the provision for adjustment hereinafter set forth) equal to the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is converted or exchanged. In the event the Corporation shall at any time after the Rights Dividend Declaration Date (i) declare any dividend on outstanding shares of Common Stock payable in shares of Common Stock; (ii) subdivide outstanding shares of Common Stock; or (iii) combine outstanding shares of Common Stock into a smaller number of shares, then in each such case the amount set forth in the immediately preceding sentence with respect to the exchange or conversion of Units of Series A Preferred Stock shall be adjusted by multiplying such amount by a fraction the numerator of which shall be the number of shares of Common Stock that are outstanding immediately after such event and the denominator of which shall be the number of shares of Common Stock that were outstanding immediately prior to such event.

 

(g)          Redemption . The Units of Series A Preferred Stock shall not be redeemable at the option of the Corporation or any holder thereof. Notwithstanding the foregoing sentence of this Section, the Corporation may acquire Units of Series A Preferred Stock in any other manner permitted by law and the Certificate of Incorporation or Bylaws of the Corporation.

 

(h)          Ranking . The Units of Series A Preferred Stock shall rank junior to all other series of the Preferred Stock and to any other class of Preferred Stock that hereafter may be issued by the Corporation as to the payment of dividends and the distribution of assets, unless the terms of any such series or class shall provide otherwise.

 

(i)           Amendment . The Certificate of Incorporation, including without limitation the provisions hereof, shall not hereafter be amended, either directly or indirectly, or through merger or share exchange with another corporation, in any manner that would alter or change the powers, preferences or special rights of the Series A Preferred Stock so as to affect the holders thereof adversely without the affirmative vote of the holders of a majority or more of the outstanding Units of Series A Preferred Stock, voting separately as a class.

 

(j)            Fractional Shares . The Series A Preferred Stock may be issued in Units or other fractions of a share, which Units or fractions shall entitle the holder, in proportion to such

 


holder’s fractional shares, to exercise voting rights, receive dividends, participate in distributions and to have the benefit of all other rights of holders of Series A Preferred Stock.

 

FIFTH :

 

(a)           The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors. Except as otherwise fixed by or pursuant to the provisions of Article FOURTH hereof relating to the rights of the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation to elect additional directors under specified circumstances, the number of directors shall be fixed by or in the manner provided in the by-laws of the Corporation.

 

(b)          The directors, other than those who may be elected by the holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation, shall be divided into three classes, designated Class I, Class II and Class III. Each class shall consist, as nearly equal in number as possible, of one-third of the total number of directors constituting the entire Board of Directors. At each annual meeting of stockholders, successors to the class of directors whose term expires at that annual meeting shall be elected for a three-year term. If the number of directors is changed, any increase or decrease shall be apportioned among the classes so as to maintain the number of directors in each class as nearly equal as possible.

(c)           A director shall hold office until the annual meeting of stockholders for the year in which his or her term expires and until his or her successor shall be elected and shall qualify, subject, however, to prior death, resignation, retirement, disqualification or removal from office. Any additional director of any class appointed or elected to fill a vacancy resulting from an increase in such class shall hold office for a term that shall coincide with the remaining term of that class, but in no case will a decrease in the number of directors shorten the term of any incumbent director.

 

(d)          Elections of directors need not be by written ballot unless the by-laws of the Corporation so provide.

 

SIXTH : In furtherance and not in limitation of the powers conferred by statute and unless otherwise provided herein, the Board of Directors, by a majority vote taken at any meeting at which a quorum is present, is expressly authorized to make, alter or repeal the by-laws of the Corporation.

 

SEVENTH : No director of the Corporation shall be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, provided, however, that this provision shall not eliminate or limit the liability of a director (i) for any breach of the director's duty of loyalty to the Corporation or its stockholders, (ii)for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii)under Section 174 of the Delaware General Corporation Law or (iv)for any transaction from which the director derived an improper personal benefit.

 


 

EIGHTH :

 

(a)           Right to Indemnification . Each person who was or is made a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a "proceeding"), by reason of the fact that he or she is or was a director or an officer of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan (hereinafter an "indemnitee"), whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent or in any other capacity while serving as a director, officer, employee or agent, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the Delaware General Corporation Law, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide prior to such amendment), against all expense, liability and loss (including attorneys' fees, judgments, fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by such indemnitee in connection therewith; provided, however, that, except as provided in Section (c) of this Article EIGHTH with respect to proceedings to enforce rights to indemnification, the Corporation shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors of the Corporation.

 

(b)          Right to Advancement of Expenses . The right to indemnification conferred in Section (a) of this Article EIGHTH shall include the right to be paid by the Corporation the expenses (including attorneys' fees) incurred in defending any such proceeding in advance of its final disposition (hereinafter an "advancement of expenses"); provided, however, that, if the Delaware General Corporation Law requires, an advancement of expenses incurred by an indemnitee in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the Corporation of an undertaking (hereinafter an "undertaking"), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal (hereinafter a "final adjudication") that such indemnitee is not entitled to be indemnified for such expenses under this Section (b) or otherwise. The rights to indemnification and to the advancement of expenses conferred in Sections (a) and (b) of this Article EIGHTH shall be contract rights and such rights shall continue as to an indemnitee who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the indemnitee's heirs, executors and administrators.

 

(c)           Right of Indemnitee to Bring Suit . If a claim under Section (a) or (b) of this Article EIGHTH is not paid in full by the Corporation within sixty (60) days after a written claim has been received by the Corporation, except in the case of a claim for an advancement of expenses, in which case the applicable period shall be twenty (20) days, the indemnitee may at

 


any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit. In (i) any suit brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense that, and (ii) in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that, the indemnitee has not met any applicable standard for indemnification set forth in the Delaware General Corporation Law. Neither the failure of the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in the Delaware General Corporation Law, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) that the indemnitee has not met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article EIGHTH or otherwise shall be on the Corporation.

 

(d)           Non-Exclusivity of Rights . The rights to indemnification and to the advancement of expenses conferred in this Article EIGHTH shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, the Corporation's Restated Certificate of Incorporation, by-laws, agreement, vote of stockholders or disinterested directors or otherwise.

 

(e)           Insurance . The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the Delaware General Corporation Law.

 

(f)           Indemnification of Employees and Agents of the Corporation . The Corporation may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation to the fullest extent of the provisions of this Article EIGHTH with respect to the indemnification and advancement of expenses of directors and officers of the Corporation.

 

NINTH : No amendment to or repeal of Article SEVENTH or EIGHTH of this Restated Certificate of Incorporation shall apply to or have any effect on the rights of any individual referred to in Article SEVENTH or EIGHTH for or with respect to acts or omissions of such individual occurring prior to such amendment or repeal.

 


 

TENTH :

 

 

A.

Vote Required For Certain Business Combinations

 

1.            In addition to any affirmative vote required by law or this Restated Certificate of Incorporation, and except as otherwise expressly provided in Section B of this Article TENTH:

 

(a)           any merger or consolidation of the Corporation or any Subsidiary (as hereinafter defined) with (i) any Interested Stockholder (as hereinafter defined) or (ii) any other corporation (whether or not itself an Interested Stockholder) which is, or after such merger or consolidation would be, an Affiliate (as hereinafter defined) of an Interested Stockholder; or

 

(b)           any sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of transactions) to or with any Interested Stockholder or any Affiliate of any Interested Stockholder of any assets of the Corporation or any Subsidiary having an aggregate Fair Market Value of $30,000,000 or more; or

 

(c)           the issuance or transfer by the Corporation or any Subsidiary (in one transaction or a series of transactions) of any securities of the Corporation or any Subsidiary to any Interested Stockholder or any Affiliate of any Interested Stockholder in exchange for cash, securities or other property (or a combination thereof) having an aggregate Fair Market Value of $10,000,000 or more; or

 

(d)           the adoption of any plan or proposal for the liquidation or dissolution of the Corporation proposed by or on behalf of an Interested Stockholder or any Affiliate of any Interested Stockholder; or

 

(e)           any reclassification of securities (including any reverse stock split), or recapitalization of the Corporation, or any merger or consolidation of the Corporation with any of its Subsidiaries or any other transaction (whether or not with or into or otherwise involving an Interested Stockholder) which has the effect, directly or indirectly, of increasing the proportionate share of the outstanding shares of any class of equity or convertible securities of the Corporation or any Subsidiary which is directly or indirectly owned by any Interested Stockholder or any Affiliate of any Interested Stockholder;

 

shall require the affirmative vote of the holders of at least 80% of the voting power of the then outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors (the "Voting Stock"), excluding shares held by the Interested Stockholder, voting together as a single class (it being understood that for purposes of this Article TENTH, each share of the Voting Stock shall have the number of votes granted to it pursuant to Article FOURTH of this Restated Certificate of Incorporation). Such affirmative vote shall be required notwithstanding the fact that no vote may be required, or that a lesser percentage may be specified, by law or in any agreement with any national securities exchange or otherwise.

 


2.            The term "Business Combination" as used in this Article TENTH shall mean any transaction which is referred to in any one or more of subparagraphs (a) through (e) of paragraph 1 of this Section A.

 

B.            When Higher Vote Is Not Required . The provisions of Section A of this Article TENTH shall not be applicable to any particular Business Combination, and such Business Combination shall require only such affirmative vote as is required by law and any other provision of this Restated Certificate of Incorporation, if all of the conditions specified in either of the following paragraphs 1 or 2 are met:

 

1.            The Business Combination shall have been approved by a majority of the Disinterested Directors (as hereinafter defined).

 

 

2.

All of the following conditions shall have been met:

 

(a)           The aggregate amount of the cash and the Fair Market Value (as hereinafter defined) as of the date of the consummation of the Business Combination of consideration other than cash to be received per share by holders of Common Stock in such Business Combination shall be at least equal to the higher of the following:

 

I. (if applicable) the Highest Per Share Price (as hereinafter defined) (including the brokerage commissions, transfer taxes and soliciting dealers' fees) paid by the Interested Stockholder for any shares of Common Stock acquired by it (X) within the two year period immediately prior to the first public announcement of the proposal of the Business Combination (the "Announcement Date") or (Y) in the transaction in which it became an Interested Stockholder, whichever is higher; and

 

II. the Fair Market Value per share of Common Stock on the Announcement Date or on the date on which the Interested Stockholder became an Interested Stockholder (such latter date is referred to in this Article TENTH as the "Determination Date"), whichever is higher.

 

(b)           The aggregate amount of the cash and the Fair Market Value as of the date of the consummation of the Business Combination of consideration other than cash to be received per share by holders of shares of any class of outstanding Voting Stock other than Common Stock shall be at least equal to the highest of the following (it being intended that the requirements of this subparagraph (b) shall be required to be met with respect to every such class of outstanding Voting Stock, whether or not the Interested Stockholder has previously acquired any shares of a particular class of Voting Stock):

 

I. (if applicable) the Highest Per Share Price (as hereinafter defined) (including any brokerage commissions, transfer taxes and soliciting dealers' fees) paid by the Interested Stockholder for any shares of such class of Voting Stock acquired by it (X) within the two-year period immediately prior to the Announcement Date or (Y) in the transaction in which it became an Interested Stockholder, whichever is higher;

 


 

II. (if applicable) the highest preferential amount per share to which the holders of shares of such class of Voting Stock are entitled in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation; and

 

III. the Fair Market Value per share of such class of Voting Stock on the Announcement Date or on the Determination Date, whichever is higher.

 

(c)           The consideration to be received by holders of a particular class of outstanding Voting Stock (including Common Stock) shall be in cash or in the same form as the Interested Stockholder has previously paid for shares of such class of Voting Stock. If the Interested Stockholder has paid for shares of any class of Voting Stock with varying forms of consideration, the form of consideration for such class of Voting Stock shall be either cash or the form used to acquire the largest number of shares of such class of Voting Stock previously acquired by it.

 

(d)          After such Interested Stockholder has become an Interested Stockholder and prior to the consummation of such Business Combination: (i) except as approved by a majority of the Disinterested Directors, there shall have been no failure to declare and pay at the regular date therefor any full quarterly dividends (whether or not cumulative) on any outstanding Preferred Stock; (ii) there shall have been (x) no reduction in the annual rate of dividends paid on the Common Stock (except as necessary to reflect any subdivision of the Common Stock), except as approved by a majority of the Disinterested Directors, and (y) an increase in such annual rate of dividends as necessary to reflect any reclassification (including any reverse stock split), recapitalization, reorganization or any similar transaction which has the effect of reducing the number of outstanding shares of the Common Stock, unless the failure so to increase such annual rate is approved by a majority of the Disinterested Directors; and (iii) such Interested Stockholder shall have not become the beneficial owner of any additional shares of Voting Stock except as part of the transaction which results in such Interested Stockholder becoming an Interested Stockholder.

 

(e)           After such Interested Stockholder has become an Interested Stockholder, such Interested Stockholder shall not have received the benefit, directly or indirectly (except proportionately as a stockholder), of any loans, advances, guarantees, pledges or other financial assistance or any tax credits or other tax advantages provided by the Corporation, whether in anticipation of or in connection with such Business Combination or otherwise.

 

(f)           A proxy or information statement describing the proposed Business Combination and complying with the requirements of the Securities Exchange Act of 1934, as amended ("Exchange Act"), and the rules and regulations thereunder (or any subsequent provisions replacing the Exchange Act, rules or regulations) shall be mailed to public stockholders of the Corporation at least 30 days prior to the consummation of such Business Combination (whether or not such proxy or information statement is required to be mailed pursuant to the Exchange Act or subsequent provisions).

 


 

 

C.

Certain Definitions . For the purposes of this Article TENTH:

 

 

1.

A "person" shall mean any individual, firm, corporation or other entity.

 

2.            "Interested Stockholder" shall mean any person (other than the Corporation or any Subsidiary) who or which:

 

(a)           is the beneficial owner, directly or indirectly, of more than 20% of the voting power of the outstanding Voting Stock; or

 

(b)           is an Affiliate of the Corporation and at any time within the two-year period immediately prior to the date in question was the beneficial owner, directly or indirectly, within the meaning of Rule13d-3 under the Exchange Act, of 20% or more of the voting power of the then outstanding Voting Stock; or

 

(c)           is an assignee of or has otherwise succeeded to any shares of Voting Stock which were at any time within the two-year period immediately prior to the date in question beneficially owned by any Interested Stockholder, if such assignment or succession shall have occurred in the course of a transaction or series of transactions not involving a public offering within the meaning of the Securities Act of 1933.

 

 

3.

A person shall be a "beneficial owner" of any Voting Stock:

 

(a)           which such person or any of its Affiliates or Associates (as hereinafter defined) beneficially owns, directly or indirectly, within the meaning of Rule13d-3 under the Exchange Act; or

 

(b)           which such person or any of its Affiliates or Associates has (i) the right to acquire (whether such right is exercisable immediately or only after the passage of time), pursuant to any agreement, arrangement or understanding or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise, or (ii) the right to vote pursuant to any agreement, arrangement or understanding (but neither such person nor any such Affiliate or Associate shall be deemed to be the beneficial owner of any shares of Voting Stock solely by reason of a revocable proxy granted for a particular meeting of stockholders, pursuant to a public solicitation of proxies for such meeting, and with respect to which shares neither such person nor any such Affiliate or Associate is otherwise deemed the beneficial owner); or

 

(c)           which are beneficially owned, directly or indirectly, within the meaning of Rule13d-3 under the Exchange Act, by any other person with which such person or any of its Affiliates or Associates has any agreement, arrangement or understanding for the purposes of acquiring, holding, voting (other than solely by reason of a revocable proxy as described in subparagraph (b) of this paragraph (3)) or disposing of any shares of Voting Stock;

 

provided , however , that in the case of any employee stock ownership or similar plan of the Corporation or of any Subsidiary in which the beneficiaries thereof possess the right to vote any

 


shares of Voting Stock held by such plan, no such plan nor any trustee with respect thereto (nor any Affiliate of such trustee), solely by reason of such capacity of such trustee, shall be deemed, for any purposes hereof, to beneficially own any shares of Voting Stock held under any such plan.

 

4.             For the purposes of determining whether a person is an Interested Stockholder pursuant to paragraph 2 of this Section C, the number of shares of Voting Stock deemed to be outstanding shall include shares deemed owned by such person through application of paragraph 3 of this Section C but shall not include any other shares of Voting Stock which may be issuable pursuant to any agreement, arrangement or understanding, or upon exercise of conversion rights, warrants or options, or otherwise.

 

5.            "Affiliate" or "Associate" shall have the respective meanings ascribed to such terms in Rule 12b-2 of the General Rules and Regulations under the Exchange Act.

 

6.            "Subsidiary" means any corporation of which a majority of any class of equity security is owned, directly or indirectly, by the Corporation; provided, however, that for the purposes of the definition of Interested Stockholder set forth in paragraph 2 of this Section C, the term "Subsidiary" shall mean only a corporation of which a majority of each class of equity security is owned, directly or indirectly, by the Corporation.

 

7.            "Disinterested Director" means any member of the Board of Directors who is unaffiliated with the Interested Stockholder and was a member of the Board of Directors prior to the time that the Interested Stockholder became an Interested Stockholder, and any successor of a Disinterested Director who is unaffiliated with the Interested Stockholder and is recommended to succeed a Disinterested Director by a majority of Disinterested Directors then on the Board of Directors.

 

8.            "Fair Market Value" means: (a) in the case of stock, the highest closing sale price during the 30-day period immediately preceding the date in question of a share of such stock on the Composite Tape for New York Stock Exchange-Listed Stocks, or, if such stock is not quoted on the Composite Tape, on the New York Stock Exchange, or, if such stock is not listed on such Exchange, on the principal United States securities exchange registered under the Exchange Act on which such stock is listed, or, if such stock is not listed on any such exchange, the highest closing bid quotation with respect to a share of such stock during the 30-day period preceding the date in question on the National Association of Securities Dealers Automated Quotation System or any system then in use, or if no such quotations are available, the fair market value on the date in question of a share of such stock as determined by the Board of Directors in good faith, in each case with respect to any class of stock, appropriately adjusted for any dividend or distribution in shares of such stock or any stock split or reclassification of outstanding shares of such stock into a greater number of shares of such stock or any combination or reclassification of outstanding shares of such stock into a smaller number of shares of such stock; and (b) in the case of property other than cash or stock, the fair market value of such property on the date in question as determined by the Board of Directors in good faith.

 

 


9.            References to "Highest Per Share Price" shall in each case with respect to any class of stock reflect an appropriate adjustment for any dividend or distribution in shares of such stock or any stock split or reclassification of outstanding shares of such stock into a greater number of shares of such stock or any combination or reclassification of outstanding shares of such stock into a smaller number of shares of such stock.

 

10.          In the event of any Business Combination in which the Corporation survives, the phrase "consideration other than cash" as used in subparagraphs (a) and (b) of paragraph 2 of Section B of this Article TENTH shall include the shares of Common Stock and/or the shares of any other class of outstanding Voting Stock retained by the holders of such shares.

 

D. Powers of the Board of Directors . A majority of the directors of the Corporation shall have the power and duty to determine for the purposes of this Article TENTH, on the basis of information known to them after reasonable inquiry, (a) whether a person is an Interested Stockholder, (b) the number of shares of Voting Stock beneficially owned by any person, (c) whether a person is an Affiliate or Associate of another and (d) whether the assets which are the subject of any Business Combination have, an aggregate Fair Market Value of $30,000,000 or more, or the consideration to be received for the issuance or transfer of securities by the Corporation or any Subsidiary in any Business Combination has, an aggregate Fair Market Value of $10,000,000 or more.

 

E. No Effect on Fiduciary Obligations of Interested Stockholders . Nothing contained in this Article TENTH shall be construed to relieve any Interested Stockholder from any fiduciary obligation imposed by law.

 

F. Amendment or Repeal . Notwithstanding any other provisions of this Restated Certificate of Incorporation or the by-laws of the Corporation (and notwithstanding the fact that a lesser percentage may be specified by law, this Restated Certificate of Incorporation or the by-laws of the Corporation), the affirmative vote of the holders of 80% or more of the outstanding Voting Stock, excluding shares held by an Interested Stockholder, voting together as a single class, shall be required to amend or repeal, or adopt any provisions inconsistent with this Article TENTH.

 

ELEVENTH : No action required to be taken or which may be taken at any annual or special meeting of stockholders of the Corporation may be taken without a meeting, and the power of stockholders to consent, in writing, without a meeting, to the taking of any action is specifically denied.

 

TWELFTH : The Corporation shall not be governed by the provisions of Section203 of the General Corporation Law of the State of Delaware.

 

IN WITNESS WHEREOF, this Restated Certificate of Incorporation which restates, integrates and amends the provisions of the Certificate of Incorporation of the Corporation, and which has been duly adopted in accordance with Section 242 of the General Corporation Law of the State of Delaware, has been executed by its President and attested by its Secretary, this 20th day of August, 1991.

 


 

 

HEALTHWAYS, INC.

 

 

By: /s/ Thomas G. Cigarran

Thomas G. Cigarran

President

 

 

ATTEST:

 

/s/ Henry D. Herr

Henry D. Herr

Secretary

 

 

 

 

Exhibit 10.1

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT

 

THIS AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (the “Amendment”) is made and entered into this 13 th day of February, 2008, by and among Healthways, Inc. (formerly known as American Healthways, Inc.), a Delaware corporation (the “Corporation”), and Henry D. Herr (the “Colleague”).

 

RECITALS

 

WHEREAS, the Corporation and the Colleague are parties to that certain Employment Agreement, dated as of November 20, 2001, as amended (the “Agreement”);

 

WHEREAS , the Corporation and Colleague desire to amend the Agreement as set forth in this Amendment.

 

NOW, THEREFORE , in consideration of the premises and mutual covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, the parties hereto, intending to be legally bound, agree as follows:

 

 

1.

Section IV of the Agreement is hereby deleted in its entirety and replaced with the following:

 

“For all duties rendered by the Colleague, the Company shall pay the Colleague $100,000 per year, payable in equal monthly installments. In addition, Colleague shall receive the equity compensation equivalent to and at the time awarded to the non-management directors of the Corporation. All compensation payable hereunder shall be subject to withholding for federal income taxes, FICA and all other applicable federal, state and local withholding requirements.”

 

2.

Except as amended by this Amendment, the Agreement shall remain in full force and effect.

 

 

3.

This Amendment may be executed in counterparts, each of which shall be deemed an original, and all of which, taken together, shall constitute a complete document.

 

4.

Capitalized terms used and not otherwise defined herein shall have the meanings ascribed thereto in the Agreement.

 

[Next page is signature page.]

 


 

IN WITNESS WHEREOF , the parties have executed this Amendment to the Agreement as of the date first set forth above.

 

 

 

HEALTHWAYS, Inc.

 

By:         /s/ Ben R. Leedle Jr.

Name:  Ben R. Leedle, Jr.

Title:    President and Chief Executive Officer

 

 

 

 

HENRY D. HERR

 

By:         /s/ Henry D. Herr

Name:  Henry D. Herr

Title:

 

 

 

 

 

 

 

2

 

 

Exhibit 31.1

CERTIFICATION

 

I, Ben R. Leedle, Jr., certify that:

 

1.         I have reviewed this quarterly report on Form 10-Q of Healthways, Inc.;

 

2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances nder which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: April 8, 2008

 

 

/s/ Ben R. Leedle, Jr.

Ben R. Leedle, Jr.

President and Chief Executive Officer

 

 

 

 

Exhibit 31.2

CERTIFICATION

 

I, Mary A. Chaput, certify that:

 

1.         I have reviewed this quarterly report on Form 10-Q of Healthways, Inc.;

 

2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: April 8, 2008

 

 

/s/ Mary A. Chaput

Mary A. Chaput

Executive Vice President and Chief Financial Officer

 

 

 

Exhibit 32

 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Healthways, Inc. (the "Company") on Form 10-Q for the period ended February 29, 2008, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Ben R. Leedle, Jr., President and Chief Executive Officer of the Company, and Mary A. Chaput, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Ben R. Leedle, Jr.

Ben R. Leedle, Jr.

President and Chief Executive Officer

April 8, 2008

 

/s/ Mary A. Chaput

Mary A. Chaput

Executive Vice President and Chief Financial Officer

April 8, 2008